El estudio Solidarity, coordinado por la Organización Mundial de la Salud en más de 30 países, indica que las terapias con remdesivir, hidroxicloroquina, lopinavir/ritonavir e interferón no han te...
Read moreLa investigadora Beatriz Pelaz, del grupo BioNanoTools en el CiQUS de la USC, participará en un proyecto europeo que busca desarrollar una nueva tecnología para la obtención de imágenes moleculare...
Read moreSOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020.
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, celebrated yest...
Read moreWith the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech
Read moreThe sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, cancer being one of them. The immune system recognises and destroys cance...
Read moreWith the participation of the Breast Unit of the Arnau de Vilanova University Hospital and IRBLleida
Read moreUn equipo conjunto de hepatólogos, psiquiatras, farmacéuticos y personal de enfermería del Hospital del Mar ofrecen un seguimiento individualizado a los pacientes que es encuentran en tratamiento p...
Read moreIt has recently been described that infection by some enteroviruses – a genus of viruses that commonly cause diseases of varying severity – could potentially trigger diabetes, although its direct ...
Read moreEl consejero de Sanidad, Enrique Ruiz Escudero, ha asistido hoy a la presentación de los resultados preliminares del ensayo clínico, en el que han participado 13 hospitales españoles de los que 7 s...
Read moreCientíficos de la Universidad de Granada y del Hospital Universitario Virgen de las Nieves trabajan en este campo, en el que expertos de todo el mundo creen que es posible aumentar la resistencia bio...
Read moreThe Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...
Read more